When working with antiretroviral therapy, the combination of medicines used to control HIV infection. Also known as ART, it aims to keep the virus at undetectable levels and protect the immune system. HIV, the virus that attacks CD4 cells and weakens immunity triggers the need for these drug regimens. Successful management also depends on viral load monitoring, regular blood tests that measure the amount of virus in the blood and on choosing the right drug class based on resistance patterns.
Antiretroviral therapy encompasses drug regimens that suppress HIV replication, reduce viral load, and allow the immune system to recover. The most common drug classes—nucleoside reverse transcriptase inhibitors (NRTIs), non‑nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors, and integrase strand transfer inhibitors—each target a different step in the virus’s life cycle. Picking the right mix often relies on a recent resistance test, which tells doctors whether the virus has mutated against certain drugs. In practice, a typical first‑line regimen blends two NRTIs with an integrase inhibitor, offering strong potency with fewer side effects.
Effective therapy requires strict adherence; missing doses lets the virus rebound and can spark resistance. Studies show that taking at least 95 % of prescribed pills keeps the virus undetectable for most patients. Simple tools like daily alarms, pill boxes, or mobile apps make it easier to stay on schedule. When adherence slips, clinicians may order a repeat viral load test within a month to see if the virus is ticking up again.
Resistance testing influences the choice of antiretroviral drugs and is a cornerstone of personalized HIV care. A genotype test identifies mutations that reduce drug effectiveness, while a phenotype test shows how the virus reacts to specific medicines. Armed with this data, doctors can avoid drugs that the virus already resists and can switch to a more powerful combination when needed. This approach not only preserves future treatment options but also minimizes unnecessary side effects.
Beyond pills, supportive care improves long‑term outcomes. Regular counseling, nutrition guidance, and management of co‑infections such as hepatitis or tuberculosis help keep the body in fighting shape. Many clinics also offer peer‑support groups where patients share strategies for coping with stigma and medication fatigue. These services create a safety net that boosts adherence and makes viral suppression more achievable.
All of these pieces—drug selection, resistance testing, viral load monitoring, adherence tools, and supportive services—fit together to form a robust antiretroviral therapy plan. Below you’ll find a hand‑picked collection of articles that dive deeper into each topic, from practical buying guides for generic medications to the latest research on drug resistance. Explore the list to sharpen your understanding and take control of your HIV treatment journey.
A comprehensive comparison of Combivir (lamivudine+zidovudine) with modern HIV single‑tablet regimens, covering efficacy, side effects, cost and when each option fits.